Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial.

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disease globally, representing 31% of all global deaths. The traditional management of CVD has largely depended on the face-to-face clinic visits once the clinical events occurred. CVD contributes to and exacerbates the economic burden on households. However, most of these complications could be avoided with early diagnosis and effective prevention or interventions.